{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-189942","form_type":"8-K","ticker":"HLF","cik":"0001180262","company_name":"HERBALIFE LTD.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.356016+00:00","generated_at":"2026-05-31T14:16:45.890878+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Herbalife Q2 adj. EBITDA $180M, beats guidance; FY 2024 EBITDA raised","bullets":["Net sales $1.3B, down 2.5% YoY but constant currency up 0.2%, driven by Latin America, EMEA, Asia Pacific.","Adjusted EBITDA $180M (highest in 7 quarters), margin up 120 bps YoY; exceeds guidance.","Diluted EPS $0.05; adjusted EPS $0.54; restructuring ($0.33) and debt extinguishment ($0.07) headwinds.","Total leverage ratio reduced to 3.5x; completed sale-leaseback of Torrance, CA office in July.","Full-year 2024 guidance: net sales forecast lowered, adjusted EBITDA raised; capex reaffirmed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-189942","json":"https://secwatch.observer/filing/0001193125-24-189942.json","markdown":"https://secwatch.observer/filing/0001193125-24-189942.md","text":"https://secwatch.observer/filing/0001193125-24-189942.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1180262/000119312524189942/0001193125-24-189942-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1180262/000119312524189942/d874292d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:16:45.890878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}